These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
290 related articles for article (PubMed ID: 17976332)
1. Percutaneous stenting of superior vena cava syndrome: treatment outcome in patients with benign and malignant etiology. Barshes NR; Annambhotla S; El Sayed HF; Huynh TT; Kougias P; Dardik A; Lin PH Vascular; 2007; 15(5):314-21. PubMed ID: 17976332 [TBL] [Abstract][Full Text] [Related]
2. Follow-up results of 71 patients undergoing metallic stent placement for the treatment of a malignant obstruction of the superior vena cava. Nagata T; Makutani S; Uchida H; Kichikawa K; Maeda M; Yoshioka T; Anai H; Sakaguchi H; Yoshimura H Cardiovasc Intervent Radiol; 2007; 30(5):959-67. PubMed ID: 17546400 [TBL] [Abstract][Full Text] [Related]
3. Percutaneous treatment of superior vena cava syndrome using metallic stents. de Gregorio Ariza MA; Gamboa P; Gimeno MJ; Alfonso E; Mainar A; Medrano J; López-Marin P; Tobio R; Herrera M Eur Radiol; 2003 Apr; 13(4):853-62. PubMed ID: 12664126 [TBL] [Abstract][Full Text] [Related]
4. Use of self-expanding vascular endoprostheses in superior vena cava syndrome. García Mónaco R; Bertoni H; Pallota G; Lastiri R; Varela M; Beveraggi EM; Vassallo BC Eur J Cardiothorac Surg; 2003 Aug; 24(2):208-11. PubMed ID: 12895609 [TBL] [Abstract][Full Text] [Related]
5. Endovascular treatment of malignant superior vena cava syndrome: is bilateral wallstent placement superior to unilateral placement? Dinkel HP; Mettke B; Schmid F; Baumgartner I; Triller J; Do DD J Endovasc Ther; 2003 Aug; 10(4):788-97. PubMed ID: 14533962 [TBL] [Abstract][Full Text] [Related]
6. Endovascular treatment of malignant superior vena cava syndrome secondary to lung cancer. Calsina Juscafresa L; Gil Bazo I; Grochowicz L; Páramo Alfaro M; López-Picazo González JM; Moreno Jiménez M; Bilbao Jaureguizar JI Hosp Pract (1995); 2017 Aug; 45(3):70-75. PubMed ID: 28618844 [TBL] [Abstract][Full Text] [Related]
7. Endovascular stenting in the management of malignant superior vena cava obstruction: comparing safety, effectiveness, and outcomes between primary stenting and salvage stenting. Leung ST; Sung TH; Wan AY; Leung KW; Kan WK Hong Kong Med J; 2015 Oct; 21(5):426-34. PubMed ID: 26139689 [TBL] [Abstract][Full Text] [Related]
8. Stent placement for the treatment of malignant superior vena cava syndrome - a single-center series of 56 patients. Sobrinho G; Aguiar P Arch Bronconeumol; 2014 Apr; 50(4):135-40. PubMed ID: 24360084 [TBL] [Abstract][Full Text] [Related]
9. Stenting as first option for endovascular treatment of malignant superior vena cava syndrome. Lanciego C; Chacón JL; Julián A; Andrade J; López L; Martinez B; Cruz M; García-García L AJR Am J Roentgenol; 2001 Sep; 177(3):585-93. PubMed ID: 11517051 [TBL] [Abstract][Full Text] [Related]
10. [Effectiveness of endovascular prostheses as initial treatment for superior vena cava syndrome of malignant cause]. Talens A; Ferrer S; González-Cruz A; Blanco E; García-Ferrer L; Iranzo V; Camps C Med Clin (Barc); 2013 Jan; 140(2):59-65. PubMed ID: 22237043 [TBL] [Abstract][Full Text] [Related]
11. Endovascular stenting for treatment of superior vena cava syndrome. Karaca O; Akçakoyun M; Esen O; Esen AM Turk Kardiyol Dern Ars; 2009 Sep; 37(6):414-6. PubMed ID: 20019457 [TBL] [Abstract][Full Text] [Related]
12. Endovascular stenting for end-stage lung cancer patients with superior vena cava syndrome post first-line treatments - A single-center experience and literature review. Kuo TT; Chen PL; Shih CC; Chen IM J Chin Med Assoc; 2017 Aug; 80(8):482-486. PubMed ID: 28501315 [TBL] [Abstract][Full Text] [Related]
13. Endovascular stenting as the first step in the overall management of malignant superior vena cava syndrome. Lanciego C; Pangua C; Chacón JI; Velasco J; Boy RC; Viana A; Cerezo S; García LG AJR Am J Roentgenol; 2009 Aug; 193(2):549-58. PubMed ID: 19620456 [TBL] [Abstract][Full Text] [Related]
14. Percutaneous stenting of superior vena cava syndrome: a case report and review of the literature. Hochrein J; Bashore TM; O'Laughlin MP; Harrison JK Am J Med; 1998 Jan; 104(1):78-84. PubMed ID: 9528723 [TBL] [Abstract][Full Text] [Related]
16. Kissing Viabahn VBX stent graft reconstruction of thoracic central veins for management of superior vena cava syndrome. Shin DS; Jackson TR; Bertino FJ; Monroe EJ; Hage AN; Lee E; Ingraham CR; Vaidya S; Chick JFB J Vasc Surg Venous Lymphat Disord; 2022 Nov; 10(6):1279-1287.e1. PubMed ID: 35843595 [TBL] [Abstract][Full Text] [Related]
17. Stent Implantation for Superior Vena Cava Syndrome of Malignant Cause. Büstgens FA; Loose R; Ficker JH; Wucherer M; Uder M; Adamus R Rofo; 2017 May; 189(5):423-430. PubMed ID: 28152555 [No Abstract] [Full Text] [Related]
18. Percutaneous endovascular Y-stenting of a malignant superior vena cava and innominate vein obstruction. Cordial R; Moussavian MR; Corvalan J; Görtz H; Teßarek J Vasc Endovascular Surg; 2014 Jan; 48(1):77-9. PubMed ID: 24122722 [TBL] [Abstract][Full Text] [Related]
19. Percutaneous transluminal stenting for superior vena cava syndrome caused by malignant tumors: a single-center retrospective study. Liu H; Li Y; Wang Y; Yan L; Zhou P; Han X J Cardiothorac Surg; 2021 Mar; 16(1):39. PubMed ID: 33743767 [TBL] [Abstract][Full Text] [Related]